Enorama Pharma AbOMXSTO: ERMA

Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln

· Issued by Enorama Pharma Ab

Enorama Pharma AB OMXSTO:ERMA:

  • Q3 NET SALES -193 (7,481) THOUSAND SEK

  • Q3 OPERATING PROFIT -12,339 (-4,476) THOUSAND SEK